Abuzenadah AM

References (5)

Title : Silver nanoparticles from leaf extract of Mentha piperita: Eco-friendly synthesis and effect on acetylcholinesterase activity - Khatoon_2018_Life.Sci_209_430
Author(s) : Khatoon A , Khan F , Ahmad N , Shaikh S , Rizvi SMD , Shakil S , Al-Qahtani MH , Abuzenadah AM , Tabrez S , Ahmed ABF , Alafnan A , Islam H , Iqbal D , Dutta R
Ref : Life Sciences , 209 :430 , 2018
Abstract :
PubMedSearch : Khatoon_2018_Life.Sci_209_430
PubMedID: 30138593

Title : Kinetics and Molecular Docking Study of an Anti-diabetic Drug Glimepiride as Acetylcholinesterase Inhibitor: Implication for Alzheimer's Disease-Diabetes Dual Therapy - Rizvi_2016_Neurochem.Res_41_1475
Author(s) : Rizvi SM , Shaikh S , Naaz D , Shakil S , Ahmad A , Haneef M , Abuzenadah AM
Ref : Neurochem Res , 41 :1475 , 2016
Abstract :
PubMedSearch : Rizvi_2016_Neurochem.Res_41_1475
PubMedID: 26886763

Title : Prediction of Anti-Diabetic Drugs as Dual Inhibitors Against Acetylcholinesterase and Beta-Secretase: A Neuroinformatics Study - Shaikh_2016_CNS.Neurol.Disord.Drug.Targets_15_1216
Author(s) : Shaikh S , Rizvi SM , Suhail T , Shakil S , Abuzenadah AM , Anis R , Naaz D , Dallol A , Haneef M , Ahmad A , Choudhary L
Ref : CNS Neurol Disord Drug Targets , 15 :1216 , 2016
Abstract :
PubMedSearch : Shaikh_2016_CNS.Neurol.Disord.Drug.Targets_15_1216
PubMedID: 27697060

Title : Molecular interaction of human brain acetylcholinesterase with a natural inhibitor huperzine-B: an enzoinformatics approach - Alam_2014_CNS.Neurol.Disord.Drug.Targets_13_487
Author(s) : Alam A , Shaikh S , Ahmad SS , Ansari MA , Shakil S , Rizvi SM , Imran M , Haneef M , Abuzenadah AM , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :487 , 2014
Abstract :
PubMedSearch : Alam_2014_CNS.Neurol.Disord.Drug.Targets_13_487
PubMedID: 24059299

Title : Molecular interaction of the antineoplastic drug, methotrexate with human brain acetylcholinesterase: a docking study - Shakil_2012_CNS.Neurol.Disord.Drug.Targets_11_142
Author(s) : Shakil S , Kamal MA , Tabrez S , Abuzenadah AM , Chaudhary AG , Damanhouri GA
Ref : CNS Neurol Disord Drug Targets , 11 :142 , 2012
Abstract :
PubMedSearch : Shakil_2012_CNS.Neurol.Disord.Drug.Targets_11_142
PubMedID: 22483282